| Mrs Jennifer Gomez Morales, EDS | |
|
7301 Sw 57th Ct Ste 565, South Miami, FL 33143-5334 | |
| (786) 344-1779 | |
| Not Available |
| Full Name | Mrs Jennifer Gomez Morales |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 7301 Sw 57th Ct Ste 565, South Miami, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376229682 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TS0200X | Psychologist - School | SS934 (Florida) | Secondary |
| 101YM0800X | Counselor - Mental Health | MH21497 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jennifer Gomez Morales, EDS 8600 Sw 81st Ln, Miami, FL 33143-6687 Ph: (786) 344-1779 | Mrs Jennifer Gomez Morales, EDS 7301 Sw 57th Ct Ste 565, South Miami, FL 33143-5334 Ph: (786) 344-1779 |
News Archive
A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson's disease (PD) regimen, significantly improved the duration of the drugs' effectiveness in people with advanced PD, according to research by Mount Sinai School of Medicine.
Babies born to mothers who eat peanuts during pregnancy appear more prone to peanut allergy, according to research conducted by scientists at Johns Hopkins Children's Center and elsewhere and published online in the Journal of Allergy and Clinical Immunology. The research team was led by Scott Sicherer, M.D., of the Mount Sinai School of Medicine in New York.
Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach, was recognized today with the 2013 North American Drug Discovery Technology Innovation Award at the Frost & Sullivan Growth, Innovation and Leadership Awards Gala, the annual event by the global research organization that highlights the most promising new innovative technology across sectors.
Covidien, a leading global provider of healthcare products and recognized innovator in surgical stapling applications, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iDrive™ powered stapling system. This reusable stapling platform is battery-powered, enabling one-handed push-button operation of all primary controls and a reduction in the required firing force when compared to traditional endomechanical surgical staplers.
› Verified 6 days ago